News Focus
News Focus
icon url

Kam8

07/14/24 3:13 AM

#705912 RE: dennisdave #705749

Ok, may be $4-$20 after Broad franchise. Then End story. $20- $22 is my guessing for End story. BPs would not miss this golden end. And just 15000 patients per years , revenue x 10 multiple, we might see 10++
icon url

Kam8

07/14/24 3:23 AM

#705913 RE: dennisdave #705749

Thermo's post at 3/10/2023. he said on the post that something very CLOSE, then He seldom make a new post for nwbo. I am guessing he has signed NDA. You know he is a big big investor. Guessing End story not too far.
icon url

Dan88

07/14/24 7:59 AM

#705920 RE: dennisdave #705749

For God's sake, do you know what condition does Outlook's approved product treat, and what will Northwest Bio vaccine treat if approved?

And the price of each treatment, the market potential?

I tell you at MC of between 100-200 millions Outlook is fairly valued in my opinion, but what MC would you give to Northwest Bio if DCVax is approved?

You guys are just talking heads. It's dangerous to invest with that kind of mindset!
Bullish
Bullish